136 related articles for article (PubMed ID: 38128502)
1. Cytomorphological Assessment in Aspirates of Ductal Carcinoma in situ: Correlations with Histopathologic Grade, Architectural Pattern, and Invasion.
Li JJX; Chow MBCY; Ng JKM; Tsang JY; Tse GM
Acta Cytol; 2024; 68(1):45-53. PubMed ID: 38128502
[TBL] [Abstract][Full Text] [Related]
2. Recognizing breast ductal carcinoma in situ on fine-needle aspiration: a diagnostic dilemma.
Guo HQ; Zhang ZH; Zhao H; Zhao LL; Pan QJ
Diagn Cytopathol; 2013 Aug; 41(8):710-5. PubMed ID: 23729369
[TBL] [Abstract][Full Text] [Related]
3. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
4. Cytologic features of ductal carcinoma in situ in fine-needle aspiration of the breast mirror the histopathologic growth pattern heterogeneity and grading.
Sauer T; Lømo J; Garred O; Naess O
Cancer; 2005 Feb; 105(1):21-7. PubMed ID: 15593325
[TBL] [Abstract][Full Text] [Related]
5. Fine-needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ.
Sneige N; Staerkel GA
Hum Pathol; 1994 May; 25(5):485-92. PubMed ID: 8200642
[TBL] [Abstract][Full Text] [Related]
6. Comparative features of ductal carcinoma in situ and infiltrating ductal carcinoma of the breast on fine-needle aspiration biopsy.
Wang HH; Ducatman BS; Eick D
Am J Clin Pathol; 1989 Dec; 92(6):736-40. PubMed ID: 2556017
[TBL] [Abstract][Full Text] [Related]
7. Regressive change in high-grade ductal carcinoma in situ of the breast: histopathologic spectrum and biologic importance.
Wasserman JK; Parra-Herran C
Am J Clin Pathol; 2015 Sep; 144(3):503-10. PubMed ID: 26276781
[TBL] [Abstract][Full Text] [Related]
8. p63 Staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast.
Reis-Filho JS; Milanezi F; Amendoeira I; Albergaria A; Schmitt FC
J Clin Pathol; 2002 Dec; 55(12):936-9. PubMed ID: 12461063
[TBL] [Abstract][Full Text] [Related]
9. Inconclusive or erroneous fine-needle aspirates of breast with adequate and representative material: a cytologic/histologic study.
Shabb NS; Boulos FI; Chakhachiro Z; Abbas J; Abdul-Karim FW
Diagn Cytopathol; 2014 May; 42(5):405-15. PubMed ID: 24167007
[TBL] [Abstract][Full Text] [Related]
10. Cytologic diagnosis and grading of ductal carcinoma in situ.
McKee GT; Tildsley G; Hammond S
Cancer; 1999 Aug; 87(4):203-9. PubMed ID: 10455208
[TBL] [Abstract][Full Text] [Related]
11. Comparative features of comedo and noncomedo ductal carcinoma in situ of the breast on fine-needle aspiration biopsy.
Malamud YR; Ducatman BS; Wang HH
Diagn Cytopathol; 1992; 8(6):571-6. PubMed ID: 1334826
[TBL] [Abstract][Full Text] [Related]
12. Assessing invasion criteria in fine needle aspirates from breast carcinoma diagnosed as DICS or invasive carcinoma: can we identify an invasive component in addition to DCIS?
Sauer T; Garred O; Lømo J; Naess O
Acta Cytol; 2006; 50(3):263-70. PubMed ID: 16780019
[TBL] [Abstract][Full Text] [Related]
13. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
14. Intraductal carcinoma (ductal carcinoma in situ) of the breast. A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma.
Moriya T; Silverberg SG
Cancer; 1994 Dec; 74(11):2972-8. PubMed ID: 7954261
[TBL] [Abstract][Full Text] [Related]
15. Comparative features of carcinoma in situ and atypical ductal hyperplasia of the breast on fine-needle aspiration biopsy specimens.
Abendroth CS; Wang HH; Ducatman BS
Am J Clin Pathol; 1991 Nov; 96(5):654-9. PubMed ID: 1659182
[TBL] [Abstract][Full Text] [Related]
16. The significance of extracellular mucin in breast fine needle aspiration specimens.
Shield PW; Ribu DL; Cominos D
Cytopathology; 2016 Jun; 27(3):185-92. PubMed ID: 26104545
[TBL] [Abstract][Full Text] [Related]
17. Is it possible to predict underestimation in ductal carcinoma in situ of the breast? Yes, using a simple score!
Marques LC; Marta GN; de Andrade JZ; Andrade D; de Barros ACSD; Andrade FEM
Eur J Surg Oncol; 2019 Jul; 45(7):1152-1155. PubMed ID: 30665684
[TBL] [Abstract][Full Text] [Related]
18. Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ.
Takada K; Kashiwagi S; Asano Y; Goto W; Morisaki T; Takahashi K; Fujita H; Takashima T; Tomita S; Hirakawa K; Ohira M
BMC Cancer; 2020 Jun; 20(1):513. PubMed ID: 32493410
[TBL] [Abstract][Full Text] [Related]
19. Nipple aspirate fluid cytology in breast carcinoma.
Krishnamurthy S; Sneige N; Thompson PA; Marcy SM; Singletary SE; Cristofanilli M; Hunt KK; Kuerer HM
Cancer; 2003 Apr; 99(2):97-104. PubMed ID: 12704689
[TBL] [Abstract][Full Text] [Related]
20. Preoperative diagnosis of ductal carcinoma in situ of the breast over a 24-year period.
Lee AHS; Toss MS; James JJ; Hodi Z; Ellis IO; Rakha EA
Histopathology; 2023 Sep; 83(3):435-442. PubMed ID: 37356976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]